Progressive CD4+ central–memory T cell decline results in CD4+ effector–memory insufficiency and overt disease in chronic SIV infection
Year: 2007
Type: article
Abstract: Primary simian immunodeficiency virus (SIV) infections of rhesus macaques result in the dramatic depletion of CD4(+) CCR5(+) effector-memory T (T(EM)) cells from extra-lymphoid effector sites, but in most infections, an increased rate of CD4(+) memory T cell proliferation appears to prevent collapse of effector site CD4(+) T(EM) cell populations and acute-phase AIDS. Eventually, persistent SIV replication results in chronic-phase AIDS, but the responsible mechanisms remain controversial. Here, we demonstrate that in the chronic phase of progressive SIV infection, effector site CD4(+) T(EM) cell populations manifest a slow, continuous decline, and that the degree of this depletion remains a highly significant correlate of late-onset AIDS. We further show that due to persistent immune activation, effector site CD4(+) T(EM) cells are predominantly short-lived, and that their homeostasis is strikingly dependent on the production of new CD4(+) T(EM) cells from central-memory T (T(CM)) cell precursors. The instability of effector site CD4(+) T(EM) cell populations over time was not explained by increasing destruction of these cells, but rather was attributable to progressive reduction in their production, secondary to decreasing numbers of CCR5(-) CD4(+) T(CM) cells. These data suggest that although CD4(+) T(EM) cell depletion is a proximate mechanism of immunodeficiency, the tempo of this depletion and the timing of disease onset are largely determined by destruction, failing production, and gradual decline of CD4(+) T(CM) cells.
DOI: 10.1084/jem.20070567
Authors: Afam Okoye, Martin Meier-Schellersheim, Jason M. Brenchley, Shoko I. Hagen, Joshua M. Walker, Mukta Rohankhedkar, Richard Lum, John B. Edgar, Shannon L. Planer, Alfred Legasse, Andrew W. Sylwester, Michael Piatak, Jeffrey D. Lifson, Vernon C. Maino, Donald L. Sodora, Daniel C. Douek, Michael K. Axthelm, Zvi Grossman, Louis J. Picker
Institutions: Oregon National Primate Research Center, Oregon Health & Science University, Vaccine and Gene Therapy Institute, National Institute of Allergy and Infectious Diseases, Vaccine Research Center, National Cancer Institute, Science Applications International Corporation (United States), BD Biosciences (United States), The University of Texas Southwestern Medical Center, Tel Aviv University
Language: English
Topic: HIV Research and Treatment
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2146524580
